Biotechnology
Disease outbreaks, childhood immunisation, the falling cost of reading a genome, and the rise of gene therapy and CRISPR…
Tracking biotechnology and global health - WHO disease outbreak alerts mapped worldwide, global coverage of the key childhood vaccines, how the cost of sequencing a human genome fell from $95M to $525, and the growth of clinical trials and research in gene therapy, CRISPR, genomics and mRNA. Data from the WHO, NIH, ClinicalTrials.gov and PubMed.
Key Facts
NIH NHGRI (sequencing cost).
ClinicalTrials.gov (CRISPR & gene therapy trials).
Outbreaks & Immunisation
Outbreak MapWHO Disease Outbreak Map
Alerts on the Map
Latest Alerts13 Alerts
WHO disease outbreak alerts - the latest for each disease and country. The past 12 months match the Key Facts count. Tap an alert on the map or in the list to hold it in both.
ImmunisationGlobal Immunisation Coverage
The share of the world’s children given each key vaccine, 2000 to now. DTP3 - the third dose against diphtheria, tetanus and whooping cough - is the WHO’s standard measure of how well an immunisation programme reaches children. MCV is the measles vaccine, HepB hepatitis B, PCV pneumococcal.
Genomics & Biotechnology
Genome Sequencing CostCost to Sequence a Human Genome
Faster than Moore’s Law. Reading a whole human genome cost about $95M in 2001 and $525 by 2022 - a faster fall than computer chips managed. The scale is logarithmic, each step ten times the last.
Clinical TrialsClinical Trials by Therapy Type
Registered clinical trials on ClinicalTrials.gov for key biotech treatments, counting every phase and status.
CRISPR Papers Per YearCRISPR Publications Per Year
A research boom. CRISPR papers in PubMed each year. Research took off after the 2012 discovery that CRISPR could edit genes precisely.
Research PublicationsBiotech Research Publications (All Time)
Papers in PubMed for four key areas - gene therapy, CRISPR, genomics and mRNA vaccines.